IDERHA represented during the Leiden Drug Development Conference

The Leiden Drug Development Conference (LDDC), organized by Leiden University Medical Centre, Leiden University, Johnson & Johnson, and TNO was a ground-breaking event. 

The entire conference was dedicated to AI's impact on drug development, manufacturing, and healthcare. In an era of rapid technological advancement, AI is transforming industries worldwide. 

Hans Verstraete is a distinguished leader in the field of data science, currently spearheading a global team focused on developing advanced analytics solutions for clinical research with real-world data. Furthermore, Hans focuses on driving impact with data science and real-world evidence in clinical research and the implementation of inclusive and equitable practices in clinical trials through innovative real-world data analyses via IDERHA. 

Hans presented the work of IDERHA during LDDC and explained the importance of our project to data users. 

For more information check out the LDDC website here.